Page last updated: 2024-10-16

gamma-aminobutyric acid and Carcinoma, Hepatocellular

gamma-aminobutyric acid has been researched along with Carcinoma, Hepatocellular in 5 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"To investigate the expression pattern of gamma-aminobutyric acid A (GABAA) receptors in hepatocellular carcinoma (HCC) and indicate the relationship among gamma-aminobutyric acid (GABA), gamma-aminobutyric acid A receptor alpha3 subunit (GABRA3) and HCC."7.74Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. ( Guo, FJ; Hu, JY; Li, GC; Li, YH; Liu, Y; Sun, RL; Wang, JJ, 2008)
"To investigate the function of gamma-aminobutyric acid (GABA) and gamma-aminobutyric acid A receptor θ subunit (GABRQ) in hepatocellular carcinoma (HCC)."3.78GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit. ( Ju, Q; Li, F; Li, GC; Li, YD; Li, YH; Liu, Y; Liu, YH; Xie, PL, 2012)
"To investigate the expression pattern of gamma-aminobutyric acid A (GABAA) receptors in hepatocellular carcinoma (HCC) and indicate the relationship among gamma-aminobutyric acid (GABA), gamma-aminobutyric acid A receptor alpha3 subunit (GABRA3) and HCC."3.74Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. ( Guo, FJ; Hu, JY; Li, GC; Li, YH; Liu, Y; Sun, RL; Wang, JJ, 2008)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y2
Li, YH2
Guo, FJ1
Wang, JJ1
Sun, RL1
Hu, JY1
Li, GC2
Li, YD1
Liu, YH1
Li, F1
Ju, Q1
Xie, PL1
Sun, D1
Gong, Y2
Kojima, H1
Wang, G1
Ravinsky, E1
Zhang, M2
Minuk, GY3
Assy, N1

Reviews

1 review available for gamma-aminobutyric acid and Carcinoma, Hepatocellular

ArticleYear
GABA and hepatocellular carcinoma.
    Molecular and cellular biochemistry, 2000, Volume: 207, Issue:1-2

    Topics: Animals; Carcinoma, Hepatocellular; gamma-Aminobutyric Acid; Humans; Liver; Liver Neoplasms; Liver R

2000

Other Studies

4 other studies available for gamma-aminobutyric acid and Carcinoma, Hepatocellular

ArticleYear
Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit.
    World journal of gastroenterology, 2008, Dec-21, Volume: 14, Issue:47

    Topics: Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; gamma-Ami

2008
GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit.
    World journal of gastroenterology, 2012, Jun-07, Volume: 18, Issue:21

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival;

2012
Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth.
    American journal of physiology. Gastrointestinal and liver physiology, 2003, Volume: 285, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Differentiation; Cell Division; DNA, Complementary; gamma-Aminobutyr

2003
Increased GABAergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line.
    Journal of hepatology, 2000, Volume: 32, Issue:1

    Topics: Albumins; alpha-Fetoproteins; Blotting, Northern; Carcinoma, Hepatocellular; Cell Division; Dose-Res

2000